Bliss GVS Pharma Limited

NSE BLISSGVS.NS

Bliss GVS Pharma Limited Capital Expenditure for the year ending March 31, 2024: USD -3.40 M

Bliss GVS Pharma Limited Capital Expenditure is USD -3.40 M for the year ending March 31, 2024, a 70.24% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).
  • Bliss GVS Pharma Limited Capital Expenditure for the year ending March 31, 2023 was USD -11.41 M, a -17.10% change year over year.
  • Bliss GVS Pharma Limited Capital Expenditure for the year ending March 31, 2022 was USD -9.75 M, a -682.14% change year over year.
  • Bliss GVS Pharma Limited Capital Expenditure for the year ending March 31, 2021 was USD -1.25 M, a 84.43% change year over year.
  • Bliss GVS Pharma Limited Capital Expenditure for the year ending March 31, 2020 was USD -8.00 M, a -27.08% change year over year.
Key data
Date Capital Expenditure Free Cash Flow Depreciation And Amortization Deferred Income Tax
Market news
Loading...
SV Wall Street
NSE: BLISSGVS.NS

Bliss GVS Pharma Limited

CEO Mr. Gagan Harsh Sharma
IPO Date July 26, 2010
Location India
Headquarters 102, Hyde Park
Employees 831
Sector Health Care
Industries
Description

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as medicated, complexion, moisturizing, and total protection soaps. The company also exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

Similar companies

SHILPAMED.NS

Shilpa Medicare Limited

USD 8.18

0.56%

CAPLIPOINT.NS

Caplin Point Laboratories Limited

USD 23.91

2.07%

DCAL.NS

Dishman Carbogen Amcis Limited

USD 2.68

1.39%

INDOCO.NS

Indoco Remedies Limited

USD 2.88

1.89%

BALMLAWRIE.NS

Balmer Lawrie & Co. Ltd.

USD 2.27

3.12%

StockViz Staff

February 1, 2025

Any question? Send us an email